SaMD

News

Newel Health, Gerresheimer team up to help pharma embrace di...

Newel Health and Gerresheimer ally to help pharma firms embed digital endpoints, real-world data, and AI into clinical testing and commercialisation.

News

Remepy's hybrid Parkinson's therapy poised for phase 3

Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.

Digital

AI in the medical devices sector: Fostering innovation while...

Among all the changes happening in the healthcare landscape in the last few years, the advent of digital health technology stands out as one poised to fuel innovation and revolutionise heal

Newel Health, Gerresheimer team up to help pharma embrace di...

Remepy's hybrid Parkinson's therapy poised for phase 3

AI in the medical devices sector: Fostering innovation while...

ASCO 2026: First to first line in HER-2 NSCLC, with Itziar C...

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks